The field of therapeutic antibodies is rapidly evolving with advances in biotechnology. Future developments may include more personalized antibody therapies tailored to individual patient profiles, improved formulations that increase stability and reduce immunogenicity, and novel delivery methods that enhance therapeutic outcomes. Additionally, the development of multi-specific antibodies that can target multiple disease pathways simultaneously holds promise for treating complex diseases.
